비즈니스 윤리 AI 컨설팅

집

AI 프롬프트 목록

철학/종교

윤리적 의사결정 지원

${:__('collect %s',윤리적 의사결정 지원)}$

철학/종교

공리주의와 의무론의 틀을 사용하여 비즈니스의 도덕적 딜레마를 분석하고, 준수 및 인간적인 의사결정 조언을 제공합니다.

프롬프트 내용

복사

Act as a senior corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but irreversible neurological side effects with long-term use, yet discontinuing the drug would cause severe deterioration for many chronic patients. Please evaluate whether the company should proactively recall the drug and disclose risks by combining utilitarian considerations of overall well-being with deontological respect for patient informed consent, while also considering the impact on shareholder interests, employee livelihoods, and public health. Finally, output an ethical decision report containing risk assessment, stakeholder analysis, and recommended action plans, ensuring the advice complies with legal baselines and embodies corporate social responsibility.

복사

시니어 기업 윤리 컨설턴트로서 다음 구체적인 비즈니스 시나리오에 대한 심층적인 도덕적 분석을 수행하십시오. 제약 회사가 장기 복용 시 경미하지만 비가역적인 신경 부작용을 가진 베스트셀러 의약품이 발견되었지만, 중단하면 많은 만성 질환 환자의 상태가 악화되는 것을 발견한 경우를 고려하십시오. 전체적인 복지에 대한 공리주의적 고려와 환자의 사전 동의에 대한 의무론적 존중을 결합하여 주주 이익, 직원 생계, 공중보건에 미치는 영향을 고려하면서 회사가 의약품을 능동적으로 회수하고 위험을 공개해야 하는지 평가하십시오. 마지막으로, 위험 평가, 이해관계자 분석, 권장된 행동 계획을 포함하는 윤리적 의사결정 보고서를 출력하고, 그 조언이 법적 기준을 준수하고 기업의 사회적 책임을 구현하는지 확인하십시오.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

윤리적 의사결정 지원

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its long-marketed common drug has mild but irreversible neurological side effects with long-term use, yet stopping the medication carries higher risks and no alternative therapy exists. The company faces a choice between proactively recalling and disclosing the information, which could lead to massive financial losses or even bankruptcy, or hiding the information, which violates patient safety principles. Please evaluate the moral weight of this situation from both utilitarian (maximizing overall well-being) and deontological (respecting patient informed consent and autonomy) perspectives, and provide a phased action recommendation that balances shareholder interests with patient safety, focusing on how to establish a trust mechanism in an environment of information asymmetry.

윤리적 의사결정 지원

Please act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma between launching early to seize market share while accepting potential side effect risks. Please analyze the long-term impact of this decision on various stakeholders (patients, shareholders, employees, public) by combining the principle of greatest happiness from utilitarianism with the requirement for procedural justice from deontology. Output a comprehensive recommendation report including risk assessment, ethical justification, and alternative solutions, ensuring logical rigor and compliance with business ethics standards.

윤리적 의사결정 지원

Act as a corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its marketed drug causes severe side effects in a very small number of long-term users, but a recall would bankrupt the company and affect thousands of patients relying on it. Please evaluate the moral weight of three paths—recall, concealment, or limited disclosure—by combining utilitarian consequence analysis with deontological respect for human dignity, and provide a specific action framework that balances social responsibility and corporate survival, avoiding rigid instructional language and narrating the reasoning process naturally.

윤리적 의사결정 지원

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its established basic drug has potential serious side effects for a very small number of individuals with specific genetic profiles after long-term use, but the cost of recall would lead to company bankruptcy and affect medication accessibility for millions of ordinary patients. Please evaluate the ethical weights of both recall and non-recall options by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological perspective of moral responsibility for harm to individuals, and provide a balanced recommendation that balances business sustainability with moral legitimacy, focusing on how to distribute risks and responsibilities among stakeholders.

윤리적 의사결정 지원

Act as a senior corporate ethics consultant to evaluate the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but insufficiently disclosed side effects with long-term use. Continuing sales maintains stock price and employment but violates patient知情权 (right to know). Please analyze the moral conflict in this context by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting individual autonomy. Provide a comprehensive recommendation that balances legal compliance, corporate social responsibility, and long-term reputation management, ensuring the logic is rigorous and actionable.

윤리적 의사결정 지원

Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug causes mild but reversible liver damage in long-term users, affecting only 0.5% of patients, with no alternative treatments available. The company must decide whether to immediately recall and suspend sales, which would cause stock price drops and shareholder lawsuits, but might save some patients' health. Please evaluate the moral weight of both recall and non-recall options using both utilitarian (maximizing overall well-being) and deontological (respecting patient autonomy and non-maleficence) ethical frameworks, and provide a final action recommendation that balances legal compliance, corporate social responsibility, and patient interests, ensuring rigorous logic and adherence to business ethics standards.